Almost every region is seeing more children hospitalized with RSV
As the Southern Hemisphere winter approaches, Brazil finds itself navigating a familiar but sobering convergence — three respiratory viruses rising simultaneously across its vast and varied regions, filling hospital wards with the youngest and most vulnerable. Fiocruz's InfoGripe system, a sentinel watching over the nation's respiratory health, has recorded 77,000 severe cases already this year, a number that continues to climb through the final days of May and into June. The geography of illness is not uniform: RSV spreads almost everywhere, influenza A concentrates in the South, and rhinovirus takes hold in the Northeast, each virus tracing its own path through a country too large for a single story. In the face of this multiplying threat, public health voices return to the one instrument most within reach — the vaccine.
- Three viruses — RSV, influenza A, and rhinovirus — are simultaneously driving a surge in severe respiratory hospitalizations across Brazil, with 77,000 cases recorded since January.
- Children and adolescents bear the heaviest burden, with RSV filling pediatric wards in nearly every region and rhinovirus striking young people hard across the Northeast and beyond.
- The outbreak is geographically fractured: the South contends with influenza A, the Northeast with rhinovirus, and only the Center-West shows any sign of RSV retreating.
- COVID-19 has receded from the national emergency picture, though Ceará, Maranhão, and Pará remain outliers with still-elevated serious infections.
- Vaccination is being urgently reinforced as the primary — and most accessible — line of defense as the surge shows no sign of peaking through June.
Brazil is contending with a broad respiratory illness surge, documented in the latest weekly bulletin from Fiocruz released this Wednesday. During the final week of May, severe acute respiratory syndrome cases continued spreading across much of the country, driven by three distinct viruses: respiratory syncytial virus, influenza A, and rhinovirus.
RSV is the most geographically pervasive, climbing in the North, Northeast, Southeast, and South — with only the Center-West showing a recent decline. Fiocruz researcher Tatiana Portella describes the pattern as nearly universal, with more children being hospitalized across almost every region. Influenza A is carving a different path, concentrated in the South but appearing in scattered states elsewhere, including Rio Grande do Norte. Rhinovirus, meanwhile, is hitting children and adolescents with particular force, most visibly in the Northeast, while also gaining ground in parts of the South, Southeast, and in Goiás.
COVID-19 offers a rare note of relief — severe cases have declined across most of the country, with only Ceará, Maranhão, and Pará still registering elevated serious infections.
The cumulative toll so far this year stands at 77,000 severe respiratory cases. Of those, 37,000 have tested positive for a known pathogen, 27,000 have tested negative, and 6,000 still await results. As the surge presses into June, public health officials are unequivocal: vaccination against these viruses is the most reliable tool available to protect the vulnerable — above all, the children filling hospital beds across the country.
Brazil is in the grip of a respiratory illness surge. The latest weekly bulletin from Fiocruz, released Wednesday, documents a widening wave of severe acute respiratory syndrome cases spreading across much of the country during the final week of May. Three viruses are driving the hospitalizations: respiratory syncytial virus, influenza A, and rhinovirus.
The picture varies by region and by virus. Respiratory syncytial virus, which strikes hardest at young children, is climbing nearly everywhere. The exception is the Center-West, where RSV hospitalizations have actually begun to fall in recent weeks. Everywhere else—North, Northeast, Southeast, and South—the trend is upward. Tatiana Portella, a researcher tracking the outbreak through Fiocruz's InfoGripe system, describes the pattern as nearly universal: almost every region is seeing more children hospitalized with RSV.
Influenza A tells a different geographic story. It is concentrating in the South, though cases are also rising in scattered states across the Southeast and North, and notably in Rio Grande do Norte in the Northeast. Rhinovirus, the third major culprit, is hitting children and adolescents particularly hard. It has gained ground most visibly in the Northeast, but is also climbing in parts of the South and Southeast, and has appeared in Goiás.
Covid-19, by contrast, has faded from the crisis picture. Cases of severe covid have dropped across most of the country. Only three states buck the trend: Ceará, Maranhão, and Pará are still seeing elevated numbers of serious infections.
The numbers tell the scale of what is unfolding. So far this year, Brazil has recorded 77,000 cases of severe acute respiratory syndrome. Of those, 37,000 have tested positive for a known pathogen, 27,000 have tested negative, and 6,000 are still awaiting laboratory results. The system is tracking a moving target.
Against all three viruses—RSV, influenza A, and rhinovirus—the primary defense remains vaccination. Public health officials emphasize that immunization is the most reliable way to prevent infection or reduce severity. As the surge continues through June, the message is clear: vaccination is not optional, it is the tool available to slow the spread and protect the most vulnerable, especially children.
Citas Notables
We have observed an increase in RSV hospitalizations in practically all regions of the country, with the exception only of the Center-West region, where hospitalizations from the virus have declined in recent weeks.— Tatiana Portella, Fiocruz InfoGripe researcher
The primary way to protect against all these viruses is vaccination.— Fiocruz health guidance
La Conversación del Hearth Otra perspectiva de la historia
Why is RSV hitting almost everywhere except one region? Is there something different about the Center-West?
The bulletin doesn't say. It just reports the pattern. It could be vaccination rates, it could be climate, it could be timing of the season there. But the data shows it's the exception, not the rule.
Three viruses at once—is that unusual?
Not really. These respiratory viruses circulate together during certain seasons. What's notable is that they're all rising at the same time across different parts of the country, which puts pressure on hospitals all at once.
Why are children being hit so hard by RSV and rhinovirus?
Young immune systems haven't encountered these viruses before, so they have no built-in defense. RSV especially can cause serious illness in infants and small children. That's why it's tracked so carefully.
The bulletin mentions 6,000 cases still waiting for results. Why does that matter?
Because you can't know the true picture until those results come back. Those 6,000 could shift which virus is actually driving the surge. Right now you're working with incomplete information.
If vaccination is the answer, why are cases still rising?
Vaccination takes time to work, and not everyone is vaccinated. You're always chasing a moving wave. The bulletin is saying: this is what's happening now, and here's what we know works to prevent it.